Andrew D. Clouston

18.6k citations

197 papers · 11.4k indexed · 3 hit papers · h-index 57

Epidemiology top 0.2%
Hepatology top 0.1%
Surgery top 1%
Oncology top 1%
Immunology top 1%

Co-authors: Elizabeth E. Powell Julie R. Jonsson David M. Purdie Geoffrey R. Hill Graeme A. Macdonald Kelli P. A. MacDonald Rachel D. Kuns Neal I. Walker
Topics: Liver Disease Diagnosis and Treatment (84 papers)Liver Disease and Transplantation (33 papers)Liver physiology and pathology (27 papers)
Cited by: Hepatology Epidemiology Hematology
Journals: JAMA Nature Medicine Blood
Partner nations: Australia United States United Kingdom

In The Last Decade

Andrew D. Clouston

195 papers receiving 11.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer

2015 700 citations Andrew D. Clouston et al. profile →
Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and Steatosis

1999 541 citations Graeme A. Macdonald, Andrew D. Clouston et al. Hepatology profile →
The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease

2013 349 citations Elizabeth E. Powell, Kevin J. Fagan et al. Hepatology profile →

Peers

Countries citing papers authored by Andrew D. Clouston

Since Specialization

Citations

This map shows the geographic impact of Andrew D. Clouston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Clouston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Clouston more than expected).

Fields of papers citing papers by Andrew D. Clouston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Clouston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Clouston. The network helps show where Andrew D. Clouston may publish in the future.

Co-authorship network of co-authors of Andrew D. Clouston

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Clouston. A scholar is included among the top collaborators of Andrew D. Clouston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Clouston. Andrew D. Clouston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MASLD fibrosis stage F3 is morphologically and transcriptomically diverse: Implications for assessing therapeutic response 2025 ·Journal of Hepatology ·Chaoyi Li,Quan Nguyen,Katharine M. Irvine,Elizabeth E. Powell,Andrew D. Clouston	0
2	Progressive fibrosis in human MASLD is associated with spatially linked transcriptomic signatures of metabolic reprogramming and senescence 2025 ·JHEP Reports ·(unknown),(unknown),(unknown),(unknown),Daniel Radford‐Smith,(unknown),Alex M. Dickens,(unknown),(unknown),Matej Orešič,Christian M. Nefzger,Eoin O’Sullivan,Matthew J. Watt,Grant A. Ramm,Andrew D. Clouston,Katharine M. Irvine,Quan Nguyen,Elizabeth E. Powell	1
3	Therapeutic potential of macrophage colony-stimulating factor in chronic liver disease 2022 ·Disease Models & Mechanisms ·Sahar Keshvari,Berit Genz,(unknown),Melanie Caruso,(unknown),Omkar L. Patkar,(unknown),Kamil A. Sokolowski,Hilmar Ebersbach,(unknown),Kelli P. A. MacDonald,Gregory Miller,Grant A. Ramm,Allison R. Pettit,Andrew D. Clouston,Elizabeth E. Powell,David Hume,Katharine M. Irvine	8
4	Donor T-cell–derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract 2019 ·Blood Advances ·Kate H. Gartlan,Motoko Koyama,Katie E. Lineburg,(unknown),Kathleen S. Ensbey,Rachel D. Kuns,Andrea Henden,Luke Samson,Andrew D. Clouston,Angel F. López,Kelli P. A. MacDonald,Geoffrey R. Hill	19
5	IL-6 dysregulation originates in dendritic cells and mediates graft-versus-host disease via classical signaling 2019 ·Blood ·A Wilkinson,(unknown),Rachel D. Kuns,Andrea Henden,Simone A. Minnie,Kathleen S. Ensbey,Andrew D. Clouston,Ping Zhang,Motoko Koyama,Juan Hidalgo,Stefan Rose‐John,Antiopi Varelias,Slavica Vučković,Kate H. Gartlan,Geoffrey R. Hill	32
6	Acute graft-versus-host disease is regulated by an IL-17–sensitive microbiome 2017 ·Blood ·Antiopi Varelias,Kate L. Ormerod,Mark D. Bunting,Motoko Koyama,Kate H. Gartlan,Rachel D. Kuns,Nancy Lachner,Kelly R. Locke,(unknown),Andrea Henden,Ping Zhang,Andrew D. Clouston,Sumaira Z. Hasnain,Michael A. McGuckin,Bruce R. Blazar,Kelli P. A. MacDonald,Philip Hugenholtz,Geoffrey R. Hill	52
7	Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma 2015 ·Gut ·Mark Bettington,Neal I. Walker,Christophe Rosty,Ian Brown,Andrew D. Clouston,Diane McKeone,Sally‐Ann Pearson,Barbara Leggett,Vicki Whitehall	152
8	Blocking Wnt protein secretion from macrophages exacerbates liver fibrosis and hepatic progenitor cell activation 2015 ·Queensland's institutional digital repository (The University of Queensland) ·Katharine M. Irvine,Andrew D. Clouston,Antje Blumenthal,Elizabeth E. Powell	1
9	Predicting clinical outcomes in chronic liver disease: the ELF test is superior to histology and simple scores 2015 ·Queensland's institutional digital repository (The University of Queensland) ·Katharine M. Irvine,Leesa Wockner,Mihir Shanker,Kevin J. Fagan,Leigh U. Horsfall,Linda Fletcher,Jacobus Ungerer,Carel Pretorius,Gregory Miller,Andrew D. Clouston,Guy Lampe,Elizabeth E. Powell	1
10	Regional Differences and Similarities in the Personality of New Zealanders 2015 ·New Zealand journal of psychology ·Lara M. Greaves,(unknown),Gloria Fraser,(unknown),Yanshu Huang,Petar Milojev,Danny Osborne,Chris G. Sibley,(unknown),Joseph Bulbulia,Marc Wilson,James H. Liu,Andrew D. Clouston	8
11	Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury 2013 ·Laboratory Investigation ·Terrence Tan,Dorothy H. Crawford,(unknown),V. Nathan Subramaniam,Andrew D. Clouston,Denis I. Crane,Kim R. Bridle,Gregory J. Anderson,Linda Fletcher	93
12	The progression of NAFLD to NASH in a mouse model of Hfe(-/-)- associated steatohepatitis is attenuated by co-administration of curcumin and vitamin E 2012 ·Hepatology ·(unknown),(unknown),Laurence Britton,Terrence Tan,Andrew D. Clouston,Kim R. Bridle,Gregory J. Anderson,Graeme A. Macdonald,Linda Fletcher,V. Nathan Subramaniam,Dorothy H. Crawford	2
13	Genome-Wide Copy Number Analysis in Esophageal Adenocarcinoma Using High-Density Single-Nucleotide Polymorphism Arrays 2008 ·Cancer Research ·Derek J. Nancarrow,Herlina Y. Handoko,B. Mark Smithers,D. C. Gotley,Paul A. Drew,David I. Watson,Andrew D. Clouston,Nicholas K. Hayward,David C. Whiteman,(unknown)	65
14	Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis # 2008 ·Hepatology ·Dorothy H. Crawford,Therese L. Murphy,Louise E. Ramm,Linda Fletcher,Andrew D. Clouston,Gregory J. Anderson,V. Nathan Subramaniam,Lawrie W. Powell,Grant A. Ramm	38
15	Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction 2007 ·Gastroenterology ·Michelle M. Richardson,Julie R. Jonsson,Elizabeth E. Powell,Elizabeth M. Brunt,Brent A. Neuschwander‐Tetri,Prithi S. Bhathal,John B. Dixon,Martin Weltman,Herbert Tilg,Alexander R. Moschen,David M. Purdie,Anthony J. Demetris,Andrew D. Clouston	359
16	TGF-beta and allogeneic stem cell transplantation: friend or foe? 2005 ·Bone Marrow Transplantation ·Tatjana Banovic,Katherine N. MacDonald,Emma Morris,Rowe,Rachel D. Kuns,Alistair Don,Steve Ledbetter,Andrew D. Clouston,Geoffrey R. Hill	10
17	Hepatic progenitor cell expansion and a periportal ductular reaction in NAFLD - Relationship with impaired hepatocyte proliferation and fibrosis, and reversal with treatment 2005 ·Hepatology ·Michelle M. Richardson,J. R. Jonsson,Elizabeth E. Powell,Elizabeth M. Brunt,P. S. Bhathal,Jeannette L. Dixon,Andrew D. Clouston	2
18	Fibrosis in chronic hepatitis C correlates significantly with circulating C-peptide and insulin levels 2002 ·Hepatology ·J. R. Jonsson,Ingrid J. Hickman,Andrew D. Clouston,Samuel Y. Ash,Johannes B. Prins,(unknown),D. Purdie,Elizabeth E. Powell	1
19	Centrilobular hepatitis with elevated autoantibody titers after liver transplantation: autoimmune hepatitis or a form of rejection? 2002 ·Hepatology ·Andrew D. Clouston,M. McCullen,(unknown),Dorothy H. Crawford	3
20	Angiotensin converting enzyme inhibition attenuates the development of hepatic fibrosis in the rat bile duct ligation model 2000 ·Hepatology ·J. R. Jonsson,Elizabeth E. Powell,Yukio Ando,(unknown),Andrew D. Clouston	1

About Andrew D. Clouston

Andrew D. Clouston is a scholar working on Hepatology, Epidemiology and Hematology, having authored 197 papers that have together received 11.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (84 papers), Liver Disease and Transplantation (33 papers) and Liver physiology and pathology (27 papers). The work is most often cited by research in Hepatology (3.8k citations), Epidemiology (4.9k citations) and Hematology (1.3k citations). Andrew D. Clouston has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Elizabeth E. Powell, Julie R. Jonsson, David M. Purdie, Geoffrey R. Hill, Graeme A. Macdonald, Kelli P. A. MacDonald, Rachel D. Kuns, Neal I. Walker, Claudia Shorthouse and Ian Brown. Their work appears in journals such as JAMA, Nature Medicine and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact